Evidence map›Paper›PMID 21436276›Full record

ArticleInvestigative ophthalmology & visual science2011

The role of N-methyl-D-aspartate receptor activation in homocysteine-induced death of retinal ganglion cells.

Preethi S Ganapathy, Richard E White, Yonju Ha, B Renee Bozard, Paul L McNeil, R William Caldwell, Sanjiv Kumar, Stephen M Black, Sylvia B Smith

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR and risk of pseudoexfoliation glaucoma: a meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2012
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Homocysteine and Glaucoma.International journal of molecular sciences · 2023
    Review
  9. Article
  10. CaBiomolecules · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Preethi S GanapathyDepartment of Cellular Biology and Anatomy, Georgia Health Sciences, University, Medical College of Georgia, Augusta, GA, USA.
Richard E White
Yonju Ha
B Renee Bozard
Paul L McNeil
R William Caldwell
Sanjiv Kumar
Stephen M Black
Sylvia B Smith
Discovery Institute · USCenter for Vascular Biology Research · US

Funding

Role of homocysteine in retinal diseaseR01EY012830 · NEI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI SMITH, SYLVIA B. · 2000 to 2016
$4.4M
NEI NIH HHS R01 EY 012830NEI NIH HHS R01 EY012830
6 · The paper itself

Abstract

purposeElevated plasma homocysteine has been implicated in glaucoma, a vision disorder characterized by retinal ganglion cell death. The toxic potential of homocysteine to ganglion cells is known, but the mechanisms are not clear. A mechanism of homocysteine-induced death of cerebral neurons is via N-methyl-D-aspartate (NMDA) receptor overstimulation, leading to excess calcium influx and oxidative stress. This study examined the role of the NMDA receptor in homocysteine-mediated ganglion cell death.

methodsPrimary mouse ganglion cells were used for these experiments. NMDA receptor stimulation by homocysteine was determined by patch clamp analysis and fluorescent detection of intracellular calcium. NMDA receptor involvement in homocysteine-mediated cell death was determined through assessment of lactate dehydrogenase release and TUNEL analysis. These experiments used the NMDA receptor blocker MK-801. Induction of reactive species superoxide, nitric oxide, and peroxynitrite was measured by electron paramagnetic resonance spectroscopy, chemiluminescent nitric oxide detection, and immunoblotting for nitrotyrosine, respectively.

results50 μM homocysteine stimulated the NMDA receptor in presence of 100 μM glycine. Homocysteine induced 59.67 ± 4.89% ganglion cell death that was reduced to 19.87 ± 3.03% with cotreatment of 250 nM MK-801. Homocysteine elevated intracellular calcium ∼7-fold, which was completely prevented by MK-801. Homocysteine treatment increased superoxide and nitric oxide levels by ∼40% and ∼90%, respectively, after 6 hours. Homocysteine treatment elevated peroxynitrite by ∼85% after 9 hours.

conclusionsThese experiments provide compelling evidence that homocysteine induces retinal ganglion cell toxicity through direct NMDA receptor stimulation and implicate, for the first time, the induction of oxidative stress as a potent mechanism of homocysteine-mediated ganglion cell death.

Indexed as

AnimalsAnimals, NewbornApoptosisCalciumDizocilpine MaleateElectron Spin Resonance SpectroscopyExcitatory Amino Acid AntagonistsHomocystineIn Situ Nick-End LabelingL-Lactate DehydrogenaseMiceMice, Inbred C57BLNitric OxideOxidative StressPatch-Clamp TechniquesReactive Oxygen SpeciesCalciumDizocilpine MaleateExcitatory Amino Acid AntagonistsHomocystineL-Lactate DehydrogenaseNitric OxideReactive Oxygen SpeciesReceptors, AMPAReceptors, N-Methyl-D-AspartateSuperoxides

Identifiers

PMID21436276
PMCPMC3176067
OpenAlexW1998029664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.